Date: 2016-03-03
Type of information: Nomination
Compound:
Company: Osiris Therapeutics (USA - MD)
Therapeutic area: Regenerative Medicine
Type agreement: nomination
Action mechanism:
Disease:
Details: * On March 3, 2016, Osiris Therapeutics announced that its Board of Directors, at a Board Meeting on March 3rd, 2016, confirmed the appointment of Dwayne Montgomery as the President and Chief Executive Officer. He will also serve as a Director of the company and stand for re-election by the company's Stockholders at its 2016 Annual Meeting. In addition, Osiris announced the election of Thomas M. Brandt to the position of director, upon recommendation of the Nominating Committee, and he will stand for re-election at the Annual 2016 Stockholders Meeting. Mr. Brandt joins Osiris as an independent Board Member, and given his qualifications, has been appointed to serve as a member of the company's Audit Committee. * On February 3, 2016, Osiris Therapeutics announced that Dwayne Montgomery , its current Chief Business Officer, has been appointed to serve as Interim Chief Executive Officer. Frank Czworka , currently Vice President and General Manager of Wound Care, has been promoted to Chief Operating Officer. Mr. Montgomery will replace Dr. Lode Debrabandere who today has announced his resignation for personal reasons from Osiris.
Dwayne Montgomery brings over 20 years of commercial and business development experience. He is currently the Chief Business Officer at Osiris. Prior to joining Osiris, Mr. Montgomery served as a commercial executive for venture-backed organizations in the trauma and spine markets. He held progressing roles of executive responsibility at Smith & Nephew, Inc. , serving as Vice President and General Manager for the Orthopaedic Global Trauma Business. He also held the role of Vice President Sales and Marketing for the Clinical Therapies Global Business, a division that eventually became Bioventus, Inc.
Frank Czworka has a proven track record of commercializing complex biologics. During his time at MedImmune , he held multiple commercial roles of increasing responsibility, including the National Vice President of sales, leading the large MedImmune sales force. At Osiris, Mr. Czworka led the commercial build out of the Wound Care team, which includes over 150 professionals. As Chief Operating Officer, Mr. Czworka will expand his commercial responsibilities to include Orthopaedics and Sports Medicine.
The Company's Board of Directors has undertaken a search process to identify a permanent Chief Executive Officer and has engaged an executive search firm to assist in the search. Both internal and external candidates will be considered.
Financial terms:
Latest news:
